Giri, J., & Galipeau, J. (2020). Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match. Blood Adv.
Chicago Style CitationGiri, Jayeeta, and Jacques Galipeau. "Mesenchymal Stromal Cell Therapeutic Potency Is Dependent Upon Viability, Route of Delivery, and Immune Match." Blood Adv 2020.
MLA CitationGiri, Jayeeta, and Jacques Galipeau. "Mesenchymal Stromal Cell Therapeutic Potency Is Dependent Upon Viability, Route of Delivery, and Immune Match." Blood Adv 2020.
Warning: These citations may not always be 100% accurate.